Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Computer-aided Detection for Colonoscopy

14. februar 2019 oppdatert av: Peng-Jen Chen, Tri-Service General Hospital

Computer-aided Detection With Deep Learning for Colorectal Adenoma During Colonoscopic Examination

We developed an artificial intelligent computer system with a deep neural network to analyze real-time video signals from the endoscopy station. This randomised controlled trial compared adenoma detection rate between computer-assisted colonoscopy and standard colonoscopy.

Studieoversikt

Detaljert beskrivelse

Colonoscopy is a primary screening and follow-up tool to detect colorectal cancer, a third leading cause of cancer death in Taiwan. Most colorectal cancers (CRCs) arise from preexisting adenomas, and the adenoma-carcinoma sequence offers an opportunity for the screening and prevention of CRCs. The removal of adenomatous polyps can lower the incidence of CRCs and result in reduced motality from CRCs. The adenoma detection rate, the proportion of screening colonoscopies performed by a endoscopist that detect at least one colorectal adenoma or adenocarcinoma, has been recommended as a quality indicator. The adenoma detection rate was inversely associated with the risks of interval colorectal cancer, advanced-stage interval cancer, and fatal interval cancer. However, adenoma detection rates vary widely among endoscopists in both academic and community settings. Polyp miss rates as high as 20% have been reported for high definition resolution colonoscopy. An improvement in adenoma detection rate at screening colonoscopy, translates into reduced risks of interval colorectal cancer and colorectal cancer death. Computer-aided detection of polyps might assist endoscopists to reduce the miss rate and enhance screening performance during colonoscopy. Computer-aided diagnosis and computer-aided detection are computerized systems that learn and inference in medical fields. Computer-aided diagnosis has been developed in colon polyp classification.

Computer-assisted image analysis has the potential to further aid adenoma detection but has remained underdeveloped. A notable benefit of such a system is that no alteration of the colonoscope or procedure is necessary. Machine learning with a deep neural network has been successfully applied to many areas of science and technology, such as object recognition and detection of computer vision, speech recognition, natural language processing. We developed an artificial intelligent computer system (PX-1) with a deep neural network to analyze real-time video signals from the endoscopy station. This randomised controlled trial compared ADR between computer-assisted colonoscopy and standard colonoscopy.

Studietype

Intervensjonell

Registrering (Forventet)

1000

Fase

  • Ikke aktuelt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

20 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Patients aged ≥20 years, scheduled for colonoscopy for one of the following indications for colonoscopy, were invited to participate in this study: polyp surveillance, changed bowel habits and/or bloody stools, bowel complaints, a positive family history for CRC, a positive FOBT, abdominal pain, diarrhoea, post-polypectomy surveillance.

Exclusion Criteria:

We excluded patients from this study if: (1) they had known colonic neoplasia or inflammatory or other significant colonic disease, such as patients specifically presenting for polypectomy; (2) there was open bleeding or they were receiving an emergency colonoscopy; (3) they had previously previous colonic resection; (4) they were in poor general condition (more than American Society of Anesthesiologists grade III); (5) they were receiving anticoagulant medication; (6) they had severe comorbidity, including end-stage cardiovascular, pulmonary, liver or renal disease); (7) they were not able or refused to give informed written consent; (8) following enrolment and randomisation to one of the arms, those subjects who had inadequate colon preparation or in whom the caecum could not be reached were also excluded.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Screening
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Computer-aided detection
We developed an artificial intelligent computer system with a deep neural network (PX-1) to analyze real-time video signals from the endoscopy station
Placebo komparator: Standard colonoscopy
Standard koloskopi

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Adenoma detection rate
Tidsramme: During colonoscopic examination procedure
Adenoma detection rate
During colonoscopic examination procedure

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
adenomas detected per subject
Tidsramme: During colonoscopic examination procedure
adenomas detected per subject
During colonoscopic examination procedure

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Forventet)

1. mars 2019

Primær fullføring (Forventet)

31. desember 2021

Studiet fullført (Forventet)

31. desember 2021

Datoer for studieregistrering

Først innsendt

13. februar 2019

Først innsendt som oppfylte QC-kriteriene

14. februar 2019

Først lagt ut (Faktiske)

15. februar 2019

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

15. februar 2019

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. februar 2019

Sist bekreftet

1. februar 2019

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 107-2314-B-016 -011-MY2

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere